{
  "client_id": "CLIENT_42M_20240814",
  "recommendations": [
    {
      "product_id": "ICLN",
      "product_name": "iShares Global Clean Energy ETF",
      "product_type": "ETF",
      "recommended_allocation": 0.20,
      "suitability_score": "High",
      "reasons": [
        "Strong alignment with client's interest in renewable energy.",
        "Diversified exposure to global clean energy companies.",
        "Moderate to high risk tolerance matches the fund's volatility."
      ],
      "risks": [
        "Market volatility due to regulatory changes in energy policies.",
        "Potential underperformance during periods of low oil prices.",
        "Currency risk due to global exposure."
      ],
      "fees": "0.42% expense ratio"
    },
    {
      "product_id": "XLV",
      "product_name": "Health Care Select Sector SPDR Fund",
      "product_type": "ETF",
      "recommended_allocation": 0.25,
      "suitability_score": "High",
      "reasons": [
        "Strong historical performance and stability in the healthcare sector.",
        "Low volatility compared to broader market indices.",
        "Alignment with client's interest in healthcare."
      ],
      "risks": [
        "Regulatory changes impacting healthcare companies.",
        "Potential underperformance in a high-interest-rate environment.",
        "Sector-specific risks such as drug trial failures."
      ],
      "fees": "0.10% expense ratio"
    },
    {
      "product_id": "QQQ",
      "product_name": "Invesco QQQ Trust",
      "product_type": "ETF",
      "recommended_allocation": 0.30,
      "suitability_score": "High",
      "reasons": [
        "Strong exposure to leading technology companies.",
        "High growth potential in the tech sector.",
        "Alignment with client's interest in technology."
      ],
      "risks": [
        "High volatility due to market sentiment around tech stocks.",
        "Potential regulatory risks impacting large tech firms.",
        "Concentration risk in top holdings."
      ],
      "fees": "0.20% expense ratio"
    },
    {
      "product_id": "VHT",
      "product_name": "Vanguard Health Care Index Fund ETF Shares",
      "product_type": "ETF",
      "recommended_allocation": 0.15,
      "suitability_score": "Medium",
      "reasons": [
        "Diversified exposure to the healthcare sector.",
        "Lower expense ratio compared to peers.",
        "Strong historical returns and stability."
      ],
      "risks": [
        "Exposure to regulatory changes in healthcare.",
        "Potential underperformance in economic downturns.",
        "Sector-specific risks such as patent expirations."
      ],
      "fees": "0.10% expense ratio"
    },
    {
      "product_id": "IBB",
      "product_name": "iShares Biotechnology ETF",
      "product_type": "ETF",
      "recommended_allocation": 0.10,
      "suitability_score": "Medium",
      "reasons": [
        "Focused exposure to the biotechnology sector.",
        "Potential for high growth from innovative biotech firms.",
        "Alignment with client's interest in healthcare."
      ],
      "risks": [
        "High volatility due to clinical trial outcomes.",
        "Regulatory risks impacting drug approvals.",
        "Sector-specific risks such as high R&D costs."
      ],
      "fees": "0.45% expense ratio"
    }
  ],
  "portfolio_level": {
    "expected_return": "8-10% annually",
    "expected_volatility": "Moderate to High",
    "overall_suitability": "Compliant",
    "disclosures": [
      "Diversification does not guarantee a profit or protect against a loss in a declining market.",
      "Investments in sector-specific ETFs carry concentration risk.",
      "Past performance is not indicative of future results.",
      "Fees and expenses will reduce returns.",
      "Client's restrictions on tobacco and firearms companies are respected in all recommendations."
    ]
  },
  "audit_log_reference": "AUDIT_20240814_42M_TECH_HEALTH_RENEW"
}